{"schema_version":"secwatch.filing_event.v1","accession":"0001079973-23-001113","form_type":"8-K","ticker":"CFOR","cik":"0001293818","company_name":"CapForce Inc.","filed_at":"2023-08-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.498047+00:00","generated_at":"2026-06-11T16:42:57.625723+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"OpGen Q2 revenue $0.7M; cash only through Sep 2023; going concern doubt","bullets":["Q2 2023 revenue $0.7M vs $1.0M in Q2 2022 (prior year had one-time sale); H1 2023 revenue up 15% to $1.65M.","Operating expenses $5.9M in Q2 (down from $6.2M); H1 $11.9M vs $12.6M year-over-year.","Cash $3.2M at June 30, 2023; expects cash insufficient beyond Sep 2023; substantial doubt about going concern.","Business milestones: FIND collaboration extension, Fisher Healthcare distribution for Unyvero A50 in U.S., FDA De Novo submission for UTI panel under review."],"urls":{"canonical":"https://secwatch.observer/filing/0001079973-23-001113","json":"https://secwatch.observer/filing/0001079973-23-001113.json","markdown":"https://secwatch.observer/filing/0001079973-23-001113.md","text":"https://secwatch.observer/filing/0001079973-23-001113.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1293818/000107997323001113/0001079973-23-001113-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1293818/000107997323001113/opgen_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T16:42:57.625723+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2831693627d7a32a0070e524f601a98f24f5ff1b","claim":"CapForce Inc. reported first half of 2023 results: revenue approximately $1.65 million.","evidence_excerpt":"Total revenue for the first half of 2023 was approximately $1.65 million, an increase of approximately 15% compared to approximately $1.44 million in the first half of 2022","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1293818/000107997323001113/0001079973-23-001113-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first half of 2023"},{"label":"Revenue","value":"approximately $1.65 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"bc164d7cbbfeeaebda4a8aac4580ac29acd9cd13","claim":"CapForce Inc. reported second quarter of 2023 results: revenue approximately $0.7 million.","evidence_excerpt":"Total revenue for the second quarter of 2023 was approximately $0.7 million compared to the company’s revenue of approximately $1.0 million in the second quarter of 2022","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1293818/000107997323001113/0001079973-23-001113-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"second quarter of 2023"},{"label":"Revenue","value":"approximately $0.7 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}